You have 9 free searches left this month | for more free features.

Melanocyte lineage-specific antigen gp100

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

HIV-1-infection Trial in Amsterdam (ConM SOSIP.v7 gp140, adjuvanted with MPLA liposomes)

Active, not recruiting
  • HIV-1-infection
  • ConM SOSIP.v7 gp140, adjuvanted with MPLA liposomes
  • Amsterdam, Noord-Holland, Netherlands
    Amsterdam University Medical Centers, location AMC
Jan 31, 2023

Lymphoblastic Leukemia, Lymphoblastic Leukemia in Children, Lymphoblastic Leukemia, Acute Adult Trial in Singapore (Anti-CD19

Recruiting
  • Lymphoblastic Leukemia
  • +5 more
  • Anti-CD19 CAR T-cells
  • Singapore, Singapore
  • +1 more
Dec 4, 2022

Lymphoblastic Leukemia, Lymphoblastic Leukemia, Acute, Childhood, Lymphoblastic Leukemia in Children Trial in Singapore (Phase

Recruiting
  • Lymphoblastic Leukemia
  • +4 more
  • Phase I
  • Phase II
  • Singapore, Singapore
    KK Women's and Children's hospital
Jun 20, 2022

Melanoma Trial in Houston (gp100, R848 gel, MAGE-3)

Completed
  • Melanoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jul 20, 2021

Hematologic Malignancy, Myeloid Malignancy Trial in Memphis (Ruxolitinib, Mesna, Anti-thymocyte globulin (ATG))

Recruiting
  • Hematologic Malignancy
  • Myeloid Malignancy
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Nov 7, 2022

Antigen-specific T Cells in Antisynthetase Syndrome and

Not yet recruiting
  • Antisynthetase Syndrome
  • BAL antigen-specific Th1 cells and Th17 cells, ILC and MAIT
  • Dijon, France
  • +5 more
Aug 2, 2023

Mutations and Phenotypes of Unclassifiable Inherited Bone Marrow

Recruiting
  • Inherited BMF Syndrome
  • The whole-exome sequencing
  • Sohag, Egypt
    , Faculty of Medicine, Sohag University
Jun 28, 2022

Prostate Adenocarcinoma Trial in Dallas (68-Ga PSMA11)

Not yet recruiting
  • Prostate Adenocarcinoma
  • 68-Ga PSMA11
  • Dallas, Texas
    UT Southwestern Medical Center
Sep 12, 2023

Optic Neuromyelitis Spectrum Disease Trial in China (BAT4406F Injection, BAT4406F Placebos)

Recruiting
  • Optic Neuromyelitis Spectrum Disease
  • BAT4406F Injection
  • BAT4406F Placebos
  • Baotou, China
  • +44 more
Sep 12, 2023

Hepatocellular Carcinoma Trial (IPM001)

Not yet recruiting
  • Hepatocellular Carcinoma
  • IPM001
  • (no location specified)
Sep 7, 2022

dapted Strategy Including Magnetic Resonance Imaging and

Completed
  • Prostate Cancer
  • Prostate Adenocarcinoma
    • Ankara, Turkey
      Ankara University School of Medicine
    Sep 6, 2023

    Vitiligo Trial in Cairo (Narrow band UVB)

    Active, not recruiting
    • Vitiligo
    • Narrow band UVB
    • Cairo, El Manial, Egypt
      Kasr El Ainy university hospital, Faulty of medicine,Cairo unive
    Mar 10, 2022

    Malignancy Trial in Beijing (Al18F-PSMA-BCH PET/CT)

    Recruiting
    • Malignancy
    • Al18F-PSMA-BCH PET/CT
    • Beijing, Chaoyang, China
      National Cancer Center/Cancer Hospital,Chinese Academy of Medica
    Mar 7, 2023

    HIV Trial in Rochester (MTP-PE/MF59, Env 2-3)

    Completed
    • HIV Infections
    • MTP-PE/MF59
    • Env 2-3
    • Rochester, New York
      Univ. of Rochester AVEG
    Oct 27, 2021

    Acute Leukemia of Ambiguous Lineage Trial in Suzhou (Venetoclax, azactidine)

    Recruiting
    • Acute Leukemia of Ambiguous Lineage
    • Suzhou, China
      The First Affliated Hospital of Soochow University
    Jun 14, 2023

    Prostate Cancer Trial (Dutasteride, Abiraterone)

    Not yet recruiting
    • Prostate Cancer
    • (no location specified)
    Jan 30, 2023

    Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8 Trial in Seattle

    Not yet recruiting
    • Castration-Resistant Prostate Carcinoma
    • +2 more
    • Biopsy
    • +9 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Nov 17, 2023

    Tumors Trial in Beijing ([68Ga]P3)

    Recruiting
    • Neoplasms
    • Beijing, Beijing, China
      Peking University First Hospital
    Jul 4, 2023

    Leukemia, T Cell Trial in Beijing (CD7 CART)

    Recruiting
    • Leukemia, T Cell
    • CD7 CART
    • Beijing, Hebei, China
      He bei Yan da Lu dao pei Hospital
    May 24, 2022

    Cancer, Immune System or Toxicities Suspected Trial in Paris, Saint-Cloud (blood sample)

    Recruiting
    • Cancer
    • Immune System or Toxicities Suspected
    • blood sample
    • Paris, France
    • +1 more
    Sep 16, 2022

    Primary Sjögren Syndrome Trial (68Ga-P16-093)

    Not yet recruiting
    • Primary Sjögren Syndrome
    • (no location specified)
    Sep 19, 2023

    Progressive Metastatic Prostate Cancer Trial in Worldwide (Enzalutamide, Placebo)

    Active, not recruiting
    • Progressive Metastatic Prostate Cancer
    • Beijing, China
    • +46 more
    Jan 13, 2023

    Tumors Trial in Beijing ([68Ga]P3)

    Recruiting
    • Neoplasms
    • Beijing, Beijing, China
      Peking University First Hospital
    Jun 4, 2023

    Advanced Prostate Cancer, Metastatic Prostate Cancer, Metastatic Prostate Neuroendocrine Carcinoma Trial in Boston

    Not yet recruiting
    • Advanced Prostate Cancer
    • +2 more
    • Boston, Massachusetts
    • +1 more
    Sep 25, 2023